Information

2009/09/29

The China Clinical Trials Outsourcing Congress

2009/09/10

Japan Biotech Forum: London 2009

2009/07/22

BioBusiness Asia 2009

2009/07/14

GNI Receives Important Patent Grants in China for Pirfenidone(F647) and in Australia for F351

2009/07/07

Notice of Exercise Price of Stock Option etc

2009/06/29

The NIKKAN KOGYO SHIMBUN newspaper of Japan published an article describing the fast-expanding CRO business in China. Dr. Ying Luo, CEO of GNI and Shanghai Genomics, is quoted in the article. A picture of the company’s research facility is also

2009/06/22

Notice of Granting Stock Option to employee

2009/06/22

Notice of Granting Stock Option to Consultants

2009/06/22

Notice of Granting Stock Option to Board of Directors

2009/05/15

Announcement regarding the scheduled change of governance to the company with committees and its Representative